RIDOV Pty Ltd | Businesses

RIDOV Pty Ltd

Phone: +61 3 9768 3368

Add/Update information

Reviews

Tags

• Businesses
• Science, technology & engineering
• Chemical company

23.01.2022 RIDOV is proud to announce it is proven to effective kill 99.99% of CARBAPENEM-RESISTANT ENTEROBACTERIACEAE (CRE), VANCOMYCIN-RESISTANT ENTEROCOCCI (VRE), MRSA (ANTIBIOTIC-RESISTANT GOLDEN STAPH) and provide ongoing protection for at least 72 hours. Three of the five most serious superbugs listed in this article.

19.01.2022 A BRIEF HISTORY OF SILVER! Here is some facts about Silver you may not know. It is a fact that Silver ions and silver compounds show a toxic effect on bacteria, viruses, algae and fungi.... Hippocrates, the "father of medicine" once wrote that silver had beneficial healing and anti-disease properties. The Phoenicians stored water, wine, and vinegar in silver bottles to prevent spoiling. In the early 20th century, people would put silver coins in milk bottles to prolong the milk's freshness. Today Silver is widely used in topical gels and impregnated into bandages because of its wide-spectrum anti-microbial activity. The anti-microbial properties of silver, stem from the chemical properties of its ionized form Ag+. This ion forms strong molecular bonds with other substances used by bacteria to respire, such as molecules containing sulfur, nitrogen, and oxygen. When the Ag+ ion forms with complex molecules, they are rendered unusable by bacteria depriving them of necessary compounds to thrive and grow eventually leading to their death. Silver compounds were used to prevent infection in World War I before the advent of antibiotics. Silver nitrate solution use continued, then was largely replaced by silver sulfadiazine cream, which generally became the "standard of care" for the antibacterial and antibiotic treatment of serious burns until the late 1990s. Now, other options, such as silver-coated dressings (activated silver dressings), are used in addition to SSD creams today to treat burns and infections. There has been renewed interest in silver as a broad-spectrum anti-microbial agent. RIDOV is an anti-microbial cleaning solution using active silver ion (Ag+) drawing on its success in history in the fight against bacteria we call superbugs.

18.01.2022 Welcome to the RIDOV Group, I am pleased and thank you for taking the time to visit our website, designed to be informative and progressive in the fight against bacteria SUPERBUGS. There is an extraordinary amount of historical and current medical articles detailing the health impacts on Australians today including world wide data on infectious disease resulting in people contracting bacteria SUPERBUGS, such as: Golden Staph... Methicillin-resistant Staphylococcus aureus (MRSA) Vancomycin Resistant Enterococci (VRE) Escherichia Coli (E-coli) These insidious pathogens are spreading rapidly from the confines of our hospitals to broader health services, nursing aged care homes, correctional facilities, schools, daycare centers, universities, gymnasiums, restaurants, transit train, bus and air and public places where people gather together regularly. We co-exist with the most successful colonizer on this planet, ‘bacteria’. Bacteria have their place some are good for you and some not so good. Despite the scientific effort in the fight against bad bacteria we are in constant pursuit of finding cures for new pathogens we call SUPERBUGS reveals a war we are desperately trying to win. As we advance in medical science so does the bacteria's ability to transmute, change and ADAPT to new environments. It is a scientific fact that in recent years ‘SUPERBUGS have adapted to resist multiple antibiotics that prescribed daily including the ‘last-line’ defence drugs. Although my key note is not about how ineffective antibiotics have become over the decades it is more about what RIDOV can do to assist in prevention, spread and cross contamination of these SUPERBUGS. Today there are many types of generally cleaning agents: Hypochlorite, (chlorine), strong bleach which are used in hospitals, broader health services and general public environments that are considered heavy chemical in nature. RIDOV is designed to challenge the status quo, these antiquated cleaning agents that are far from ideal in terms of being people and environmentally friendly. Today we are proud of what we have achieved, RIDOV is ‘Fit for Purpose’. A proven Anti-Microbial Compound that delivers proven results.

18.01.2022 T O YO KO OT TIIOI EITE? Response to the Australian Government, Department of Health and Agriculture Antimicrobial Resistance Strategy. KGO...Continue reading

15.01.2022 UPDATE: A DEADLY SUPERBUG has KILLED two people and may have claimed the lives of up to 18 Victorians - reported in the Hearld Sun (Victoria, Australia) 17 June 2015. The New SUPERBUG is known as Carbapenemase Resistant Enterobacteriaceae (CRE). RIDOV will continue the fight against superbugs and will be testing RIDOV against CRE with ams Laboratories Sydney. Hospitals are now on high alert with 60 people infected across the state of Victoria. Health services are today ...Continue reading

14.01.2022 Following up on our newest frontier against superbugs, Bridie Smith (Science Editor) had posted the following article in The Age today: Scientists Map Klebsiella Pneumoniae Superbug's Genome. The genome of the superbug that has put hospital authorities across the globe on alert has been mapped, raising hopes that scientists could finally tame the bacterial bandit that has been linked to Australian deaths. Known as Klebsiella pneumoniae, the superbug is resistant to antibiotic... treatment and kills about half of those it infects. In Victoria, a strain called KPC has already been detected in 57 people and is potentially behind the deaths of two patients at St Vincent's Hospital last year. The findings by an international team of researchers, including Melbourne University Bio21 scientists, established the bacteria had 30,000 genes 10,000 more than the human genome. Of these, just 1800 were common to the 300 strains studied. These shared genes are the ones that researchers will need to target when designing an antibiotic treatment for the bacterial infection or a vaccine to prevent it taking hold. "Being able to track the bacteria through their genome is really powerful," said computational biologist at Melbourne University and the Bio21 Institute, Kat Holt. "It means we can monitor individual strains that are spreading in the community." The bacteria has been identified by the World Health Organisation and the US Centres for Disease Control as an urgent and immediate threat to human health. Dr Holt said Klebsiella pneumoniae had been in the top five hospital-acquired infections globally for decades. However, it has not been well studied and scientists know little about how it causes infection. While single strains of the bacteria have been sequenced in recent years, this is the first time scientists have looked at the family tree to see how the strains are related and gained insights into how the bacteria mutates. "Every second sample we looked at was a completely new," she said. "It's very genetically diverse." Dr Holt said the bacteria was an expert at acquiring new genes, which was why it was able to mutate and evade antibiotic treatment so efficiently. The research team also identified strains that can cause infection serious enough for healthy people to require hospital treatment. These strains shared four common genes, which survived by scavenging iron from their host. "This is a potential target for drug design," Dr Holt said. "But the worrying thing is that these four genes are readily passed between the bacteria, which raises the prospect of a much more virulent strain emerging." Outlined in the journal PNAS on Tuesday, the study used samples taken from patients in Australia, Singapore, Vietnam, Laos and the United States. The 48 Australian samples came from patients admitted to the Alfred Hospital 12 years ago who were carrying the bacteria, which had been acquired both before and during their hospital stay.

08.01.2022 Mr. Robert White (Managing Director) and Mr. Michael Lenihan (Head of Projects) went on a RIDOV trade mission in Kuala Lumpur, Malaysia for a week in the beginning of June 2015. Please see the 'RIDOV Malaysia Trade Mission in June 2015' photo album for some of the photos. Amongst other fruitful meetings and networking opportunities, they had a very successful presentation to MIDA (Malaysian Investment Development Authority) who is a government body supporting foreign companies going in the Malaysian market and assists with their licensing and certification compliance.